phenyl acetate has been researched along with Cognitive Dysfunction in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Du, J; Gao, C; He, G; He, Y; Huang, P; Li, B; Tang, H; Zhang, P | 1 |
| Dietlein, M; Dillen, K; Dronse, J; Fink, GR; Jacobs, HIL; Kracht, L; Kukolja, J; Langen, KJ; Nellessen, N; Neumaier, B; Onur, OA; Richter, N | 1 |
| Gao, H; Ji, H; Jiang, Q; Li, C; Li, X; Li, Y; Ning, J; Song, W; Xu, P; Xu, Q; Yan, J; Zhang, L; Zhang, X; Zheng, H; Zheng, Y | 1 |
| Beckers, N; Dietlein, M; Fink, GR; Kracht, L; Kukolja, J; Neumaier, B; Onur, OA; Richter, N; Tittgemeyer, M | 1 |
| Chin, YW; Cho, J; Moniruzzaman, M | 1 |
| Han, HJ; Heo, HJ; Kang, JY; Kim, CW; Kim, JM; Kim, SH; Lee, U; Park, SB; Park, SK; Yoo, SK | 1 |
| Cappa, SF; Florea, I; Garibotto, V; Marcone, A; Moresco, R; Panzacchi, A; Perani, D; Rinne, J; Tettamanti, M; Virta, JR | 1 |
| Ghosh, A; Hong, H; Hu, M; Lin, JR; Long, Y; Sun, HB; Tang, SS; Wu, F; Zhang, CT | 1 |
| Dietlein, M; Fink, GR; Kracht, L; Kukolja, J; Michel, A; Neumaier, B; Onur, OA; Richter, N; Tittgemeyer, M | 1 |
| Bertoldo, A; Borroni, B; Cappa, SF; Carpinelli, A; Florea, I; Garibotto, V; Herholz, K; Marcone, A; Moresco, RM; Padovani, A; Panzacchi, A; Perani, D; Rinne, JO; Tettamanti, M; Virta, JR | 1 |
10 other study(ies) available for phenyl acetate and Cognitive Dysfunction
| Article | Year |
|---|---|
Early changes of fecal short-chain fatty acid levels in patients with mild cognitive impairments.
Topics: Acetates; Alzheimer Disease; Amyloid beta-Peptides; Atrophy; Butyric Acid; Caproates; Cognitive Dysfunction; Fatty Acids, Volatile; Humans; Positron-Emission Tomography | 2023 |
Spatial distributions of cholinergic impairment and neuronal hypometabolism differ in MCI due to AD.
Topics: Acetates; Acetylcholinesterase; Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Piperidines; Positron-Emission Tomography; Radiopharmaceuticals | 2019 |
Depletion of acetate-producing bacteria from the gut microbiota facilitates cognitive impairment through the gut-brain neural mechanism in diabetic mice.
Topics: Acetates; Animals; Bacteria; Brain; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Gastrointestinal Microbiome; Mice | 2021 |
Effect of cholinergic treatment depends on cholinergic integrity in early Alzheimer's disease.
Topics: Acetates; Acetylcholinesterase; Aged; Aged, 80 and over; Alzheimer Disease; Case-Control Studies; Cerebral Cortex; Cholinergic Agents; Cognitive Dysfunction; Female; Humans; Magnetic Resonance Imaging; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Oxygen; Piperidines; Positron-Emission Tomography; Rivastigmine | 2018 |
HO-1 dependent antioxidant effects of ethyl acetate fraction from Physalis alkekengi fruit ameliorates scopolamine-induced cognitive impairments.
Topics: Acetates; Animals; Antioxidants; Cell Line; Cognitive Dysfunction; Fruit; Glucosides; Heme Oxygenase-1; Luteolin; Male; MAP Kinase Signaling System; Memory Disorders; Mice, Inbred ICR; Physalis; Proto-Oncogene Proteins c-akt; Scopolamine | 2018 |
Ethyl Acetate Fraction from Persimmon (
Topics: Acetates; Animals; Antioxidants; Apoptosis; Brain; Cell Count; Cognition; Cognitive Dysfunction; Diospyros; JNK Mitogen-Activated Protein Kinases; Male; Maze Learning; Membrane Potential, Mitochondrial; Mice; Mitochondria; Neurons; Neuroprotective Agents; Plant Extracts; Proto-Oncogene Proteins c-akt; Pyramidal Cells; Signal Transduction | 2018 |
Cholinergic activity correlates with reserve proxies in Alzheimer's disease.
Topics: Acetates; Acetylcholine; Aged; Aged, 80 and over; Alzheimer Disease; Carbon Isotopes; Cognitive Dysfunction; Cognitive Reserve; Educational Status; Employment; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Status Schedule; Middle Aged; Piperidines; Positron-Emission Tomography; Radiography; Statistics, Nonparametric; Tomography Scanners, X-Ray Computed | 2013 |
Montelukast ameliorates streptozotocin-induced cognitive impairment and neurotoxicity in mice.
Topics: Acetates; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cognitive Dysfunction; Cyclopropanes; Disease Models, Animal; Hippocampus; Interleukin-1beta; Male; Maze Learning; Mice; Mice, Inbred ICR; Neurotoxicity Syndromes; Proto-Oncogene Proteins c-bcl-2; Quinolines; Receptors, Leukotriene; RNA, Messenger; Streptozocin; Sulfides; Tumor Necrosis Factor-alpha | 2016 |
White matter lesions and the cholinergic deficit in aging and mild cognitive impairment.
Topics: Acetates; Acetylcholinesterase; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Cognitive Dysfunction; Female; Humans; Male; Memory; Middle Aged; Neuropsychological Tests; Piperidines; Positron-Emission Tomography; White Matter | 2017 |
[11C]-MP4A PET cholinergic measurements in amnestic mild cognitive impairment, probable Alzheimer's disease, and dementia with Lewy bodies: a Bayesian method and voxel-based analysis.
Topics: Acetates; Acetylcholinesterase; Aged; Aged, 80 and over; Amnesia; Bayes Theorem; Carbon Radioisotopes; Cognitive Dysfunction; Female; Humans; Lewy Body Disease; Male; Middle Aged; Piperidines; Positron-Emission Tomography | 2012 |